NCT00605787View on ClinicalTrials.gov

TTA in Treatment of Diabetes and Dyslipidemia

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

June 30, 2003

Study Completion Date

December 31, 2007

Conditions
Type 2 Diabetes MellitusDyslipidemia
Interventions
DRUG

Tetradecylthioacetic acid (TTA)

1000mg capsules once daily for 28 days

Trial Locations (1)

5021

Haukeland University Hospital, Bergen

All Listed Sponsors
collaborator

University of Bergen

OTHER

lead

Haukeland University Hospital

OTHER

NCT00605787 - TTA in Treatment of Diabetes and Dyslipidemia | Biotech Hunter | Biotech Hunter